1.
Menzinger S, Kaya G, Schmidt E, Fontao L, Laffitte E. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid. Acta Derm Venereol [Internet]. 2017 Nov. 27 [cited 2026 Jun. 29];98(2):284-6. Available from: https://medicaljournalssweden.se/actadv/article/view/2853